Nevertheless, the targeting of intestinal Gastrin/CCKBR axis, using Gastrin‐SiO2 microspheres, could be a novel interventional strategy for controlling blood glucose levels in the clinical management of T2D. Here, GAST is linked to type 2 diabetes mellitus.